Fact.MR has announced the addition of the “Graft Delivery Devices Market Forecast, Trend Analysis & Competition Tracking - Global Review 2017 to 2027"report to their offering.

Rockville, MD -- (SBWire) -- 12/21/2018 --With the advent of advanced tissue transplantation tools or graft delivery devices, frequency and efficiency of tissue transplantation surgeries have increased dramatically. Over half a million bone grafting procedures are performed annually in the United States and the count crosses two billion across the globe. As transplantation of living tissues involves complexity and requires precision, design and development of new generation of graft delivery devices is underway in the graft delivery devices market. In addition, increasing preference for minimally invasive surgeries has led to the development of advanced graft delivery devices.

Advances in graft delivery devices have enabled surgical operations at difficult-to-reach locations. Further, the graft delivery devices are used for allograft, autograft or synthetic graft materials for targeted delivery of biomaterial, thereby maximizing the material utilization.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=576

3D Printing and Preference for Minimally Invasive Surgeries to Transform the Landscape of Graft Delivery Devices Market

In the past half a decade, the medical technology industry has introduced some of the excellent use of 3D printing. The technology of 3D printing is especially transforming the outcome of implant surgeries. Following the higher patient outcomes, stakeholders in the graft delivery devices market are introducing novel graft delivery devices. Using the advanced manufacturing technologies of 3D printing researchers have successfully enabled the fabrication of free-form biomaterials to be used in tissue regeneration. With the advent of 3D printing, researchers have been able to achieve the highest accuracy in designing bone grafts close to the shape of the original bone, thereby increasing efficiency of graft delivery devices.

Owing to disruptive innovations in the field of biomaterials and tissue engineering and growing preference for minimally invasive surgeries, the graft delivery devices landscape has witnessed a significant transformation. Stakeholders in the graft delivery devices market have introduced graft delivery devices that prominently reduce human efforts and increase the patient outcome.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=576

Graft Delivery Devices Market to Witness a Surge in Product Innovations and Clinical Approvals

The graft delivery devices marketplace is marked by the persistent introduction of new devices and partnership among leading market players. Increasing FDA approvals of graft delivery devices aligned with increasing patient outcomes are likely to present lucrative opportunities for the graft delivery devices market.

Aziyo Biologics Inc., a fully integrated regenerative medicine company has recently announced a partnership with SurGenTec, a medical device company to expand the reach of their product portfolio in the global landscape of the graft delivery devices.
SurGenTec, last year received a patent for its bone graft delivery technology used in Graftgun by the U.S. Patent and Trademark Office. This graft delivery device is said to provide a safer, efficient and ergonomic solution to deliver the bone grafts in places difficult-to-reach.
Last year, Lombard Medical had launched its new low-profile IntelliFlex LP delivery system in Japan to deliver Lombard's Aorfix AAA stent graft. The company has been recently acquired by MicroPort Scientific Corp. This restructuring step will continue the commercialization of Lombard's two graft delivery devices, Aorfix and Altura.
Recently, Medtronic plc., a leading player in the graft delivery devices market has received FDA approval for the use of its Infuse Bone Graft in new spine surgery indications.
Covera™ Vascular Covered Stent of C.R.Brad Inc. has recently received FDA approval for its use patients with AV access grafts to receive hemodialysis longer.
Although the graft delivery devices market is expected to witness a stellar growth, lack of awareness as well as skilled physicians for the complete utilization of graft delivery devices is likely to influence their adoption rates in the graft delivery devices market. In addition, advances in robotics and their implementation in minimally invasive surgery is anticipated to influence the future progress of conventional graft delivery devices. Growing penetration of robotic-assisted surgery is likely to create new avenues for the graft delivery devices market in the coming years.

Ask For Customized Report @ https://www.factmr.com/connectus/sample?flag=RC&rep_id=576

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/